- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04502524
Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans
A Scalable e-Health Smoking Cessation Intervention for Socioeconomically Disadvantaged Veterans
Study Overview
Status
Conditions
Detailed Description
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants use the new website smoking cessation program, which provides values driven, mindfulness based coping skills and utilizes non-judgmental acceptance of uncomfortable internal states like cravings. Participants also receive text messages consisting of motivational messages and reminders to use the program. At the end of the program, participants receive an email with handouts and available resources provided by the VA for continued support for smoking cessation.
ARM II: Participants use the VA standard of care website, which provides educational materials about cessation treatments, tools to cope with urges and relapse, how to stay motivated, and brief tips on coping with physical and mental health problems. Participants also receive text messages consisting of motivational messages and reminders to use the program. At the end of the program, participants receive an email with a handout of available resources provided by the VA for continued support for smoking cessation.
After study randomization, participants are followed up at 1 and 3 months.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Bedford, Massachusetts, United States, 01730
- Bedford VA Research Corporation, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants must be a US veteran
- Participants must be low-income, as defined by falling below Veterans Health Administration (VHA) national income threshold for no-cost healthcare
- Participants must be a current smoker, averaging at least 5 cigarettes/day for the last 30 days
- Participants must have weekly internet access for the next 3 months
- Participants must self-report current use of a personal email address to receive the link to their assigned web site
- Participants must self-report being willing to complete all study activities
- Participants must be willing to receive study-related text messages
Exclusion Criteria:
- Currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program
- Have recent (past 30 days) substance use disorder, suicidal ideation, or psychiatric hospitalization
- Previous participation in the treatment development stage of the new smoking cessation website program
- Prior use of the SmokefreeVET web site
- Member of the same household as another research participant
- Woman who is pregnant or breastfeeding, or planning to become pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm I (New website program, handout, text message)
Participants complete the new website smoking cessation program which provides values driven, mindfulness based coping skills and utilizes non-judgmental acceptance of uncomfortable internal states like cravings.
Participants will also receive text messages consisting of motivational messages and reminders to use the program.
At the end of the program, participants receive an email with all session handouts and available resources provided by the VA for continued support for smoking cessation.
|
Ancillary studies
Complete the new website smoking cessation program
Other Names:
Receive information about the cost of smoking, benefits of quitting, ways to prepare for quitting, ways to handle triggers and withdrawal symptoms, and available medications to help with quitting.
And will receive additional resources available at the VA handout via email at the end of the study.
Receive motivational and reminder text messages
|
|
Active Comparator: Arm II (Standard care VA website, handout, text message)
Participants use the standard of care website, which provides educational materials about cessation treatments, tools to cope with urges and relapse, how to stay motivated, and brief tips on coping with physical and mental health problems.
Participants also receive text messages consisting of motivational messages and reminders to use the program.
At the end of the program, participants receive an email with a handout of available resources provided by the VA for continued support for smoking cessation.
|
Ancillary studies
Receive information about the cost of smoking, benefits of quitting, ways to prepare for quitting, ways to handle triggers and withdrawal symptoms, and available medications to help with quitting.
And will receive additional resources available at the VA handout via email at the end of the study.
Receive motivational and reminder text messages
Complete the standard of care website smoking cessation intervention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction With Assigned Treatment
Time Frame: At 3 months post-randomization
|
Satisfaction ratings regarding the usefulness of specific components of the website program, user comments and suggestions for improvement, presented descriptively.
Treatment satisfaction items are reported on a Likert-type scale, with response choices ranging from "not at all satisfied" to "very satisfied".
Will dichotomize values at a threshold of "somewhat satisfied" or higher.
We tested for differences between arms using a Fisher's Exact test.
|
At 3 months post-randomization
|
|
Number of Server-recorded Logins to Assigned Website
Time Frame: At 3 months
|
Will use negative binomial regression with adjustment for the stratification variable and baseline readiness to quit (high versus low) to compare treatment effects on the count outcome number of logins.
There were no potential confounders to adjust for.
|
At 3 months
|
|
Duration of Website Use (Days Since First Login)
Time Frame: At 3 months
|
Will use negative binomial regression with adjustment for the stratification variable baseline readiness to quit (high versus low) to compare treatment groups on the secondary acceptability outcome of duration of site usage (number of days elapsed from first to last use).
There were no confounders to adjust for.
|
At 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Quit Attempts
Time Frame: At 3 months
|
Will use a negative binomial model with adjustment for the stratification variable and baseline readiness to quit (high versus low) to compare the count outcome number of quit attempts between arms.
There were no confounders to address for.
|
At 3 months
|
|
Cotinine-confirmed, Self-reported Abstinence From Smoking
Time Frame: In the 7 days prior to the 3-month follow up
|
Will use a logistic regression model with adjustment for the stratification variable and baseline readiness to quit (high versus low) to compare smoking abstinence between arms.
There were no confounders to adjust for.
Missing responses were considered as continued smokers.
|
In the 7 days prior to the 3-month follow up
|
|
Cotinine-confirmed, Self-reported Abstinence From Smoking
Time Frame: In the 30 days prior to the 3-month follow up
|
Will use a logistic regression model with adjustment for the stratification variable and baseline readiness to quit (high versus low) to compare smoking abstinence between arms.
There were no confounders to adjust for.
Missing responses were considered continued smokers.
|
In the 30 days prior to the 3-month follow up
|
|
Self-reported Abstinence From All Nicotine and Tobacco Products (Except Nicotine Replacement Therapy)
Time Frame: In the 7 days prior to the 3-month follow up
|
Will use a logistic regression model with adjustment for the stratification variable and baseline readiness to quit (high versus low) to compare smoking abstinence between arms.
There were no confounders to adjust for.
The missing responses were considered continued smokers.
|
In the 7 days prior to the 3-month follow up
|
|
Change in Readiness to Quit
Time Frame: Baseline up to 3-month follow-up
|
Will be assessed by the Contemplation Ladder on a scale from 0 (no thought about quitting) to 10 (taking action to quit).
Will calculate change score as follow-up minus baseline score and use a linear regression model with adjustment for the baseline value of the measure of interest and for the stratification variable and baseline readiness to quit (high versus low) to compare between study arms.
There were no confounders to adjust for.
|
Baseline up to 3-month follow-up
|
|
Change in Acceptance of Smoking Triggers
Time Frame: Baseline up to 3-month follow-up
|
Will be assessed by the Avoidance and Inflexibility Scale (AIS) on a scale ranging from 0 (never/not at all) to 4 (always/very much/extensively).
Will calculate change score as follow-up minus baseline score and use a linear regression model with adjustment for the baseline value of the measure of interest and for the stratification variable and baseline readiness to quit (high versus low) to compare between study arms.
There were no confounders to adjust for.
This is the AIS Feelings score change.
|
Baseline up to 3-month follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jaimee Heffner, Fred Hutch/University of Washington Cancer Consortium
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RG1007109
- 10097 (Other Identifier: Fred Hutch/University of Washington Cancer Consortium)
- NCI-2020-05587 (Registry Identifier: NCI / CTRP)
- R21CA236980 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cigarette Smoking-Related Carcinoma
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingCigarette Smoking-Related CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA)Not yet recruitingCigarette Smoking-Related CarcinomaUnited States
-
Roswell Park Cancer InstituteRecruitingCigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingMalignant Thoracic Neoplasm | Cigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingCigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruiting
-
M.D. Anderson Cancer CenterNational Institute on Drug Abuse (NIDA)CompletedCigarette Smoking-Related CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); New Mexico State University; National Cancer...WithdrawnCigarette Smoking-Related CarcinomaUnited States
-
University of California, San FranciscoJohns Hopkins University; National Cancer Institute (NCI); University of California... and other collaboratorsCompletedCigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingCigarette Smoking-Related CarcinomaUnited States
Clinical Trials on Questionnaire Administration
-
Fondazione Don Carlo Gnocchi OnlusCompleted
-
Centre Oscar LambretCentre Hospitalier Universitaire de BesanconTerminated
-
Hospital Clínico Universitario de ValladolidRed Centinela Sanitaria de Castilla y León (RCSCYL); Centro Nacional de Gripe... and other collaboratorsRecruitingMigraine | Headache Disorders | Viral Infection | Influenza -Like Illness | Head PainSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | COVID-19 Infection | Hereditary Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced Malignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Plasma Cell Myeloma | Caregiver | Recurrent LeukemiaUnited States
-
Gulseren Demir KarakilicCompletedMusculoskeletal Diseases | Chronic PainTurkey (Türkiye)
-
I.M. Sechenov First Moscow State Medical UniversityAgency of Social Information St. PetersburgActive, not recruiting
-
I.M. Sechenov First Moscow State Medical UniversityActive, not recruitingShoulder ArthropathyRussian Federation
-
Karolinska University HospitalSahlgrenska University Hospital, Sweden; University Hospital, Linkoeping; Skane...Active, not recruitingQuality of Life | Vulvar CancerSweden